CD BioSciences, a US-based biotechnology company focusing on the development of imaging technologies, is proud to introduce ...

Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to manufacture and sell its proprietary ...

According to Research by , Life Science Tools Market Growth is Driven by Advancements in Genomics, Personalized Medicine, and Drug Development.Austin, United States, Nov. 20, 2024 (GLOBE NEWSWIRE) -- ...

Jabs are being replaced by skin patches; US FDA has approved a nasal spray vaccine that can be bought from stores ...

Queensland’s biomedical sector will be on show at the International Conference on Microneedles 2025 (ICM 2025), set to take ...

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality.

Cancer has a high death rate with delayed diagnosis of the disease being one of the main reasons for its fatality. Early ...

The company’s products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and ...

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection with higher throughput for efficient and accurate diagnosis. Neeraj Jadhav, Industry ...